Terms: = Liver cancer AND BIRC3, AIP1, 330, ENSG00000023445, HIAP1, Q13489, MIHC, CIAP2, API2, cIAP2, MALT2, hiap-1, RNF49, HAIP1 AND Treatment
195 results:
1. Comprehensive Analysis of the Immunosuppressive Function of Regulatory T Cells in Human Hepatocellular Carcinoma Tissues.
Ge J; Chen J; Shen Q; Zheng X; Chen X; Shi L; Chen L; Xu B
Cancer Control; 2024; 31():10732748241251580. PubMed ID: 38712609
[TBL] [Abstract] [Full Text] [Related]
2. Does depressurization of the portal vein before liver transplantation affect the recurrence of HCC? A nested case-control study.
Wei G; Zhao Y; Feng S; Yuan J; Xu G; Lv T; Yang J; Kong L; Yang J
BMC Cancer; 2024 May; 24(1):558. PubMed ID: 38702621
[TBL] [Abstract] [Full Text] [Related]
3. Autoimmune pancreatitis: Cornerstones and future perspectives.
Gallo C; Dispinzieri G; Zucchini N; Invernizzi P; Massironi S
World J Gastroenterol; 2024 Feb; 30(8):817-832. PubMed ID: 38516247
[TBL] [Abstract] [Full Text] [Related]
4. Multiregion WES of metastatic pancreatic neuroendocrine tumors revealed heterogeneity in genomic alterations, immune microenvironment and evolutionary patterns.
Jiang Y; Dong YH; Zhao SW; Liu DY; Zhang JY; Xu XY; Chen H; Chen H; Jin JB
Cell Commun Signal; 2024 Mar; 22(1):164. PubMed ID: 38448900
[TBL] [Abstract] [Full Text] [Related]
5. CircNUP54 promotes hepatocellular carcinoma progression via facilitating HuR cytoplasmic export and stabilizing birc3 mRNA.
Tang C; Zhuang H; Wang W; Wang Q; Ma X; Wang B; Zhang Z; Jiang J; Xie Z; Tan W; Yang L; Liu S; Hua Y; Xiao Y; Ding B; Chen Y; Shang C
Cell Death Dis; 2024 Mar; 15(3):191. PubMed ID: 38443362
[TBL] [Abstract] [Full Text] [Related]
6. Surgery for liver metastases from primary breast cancer: A reconstructed individual patient data meta-analysis.
Masuda Y; Yeo MHX; Syn NL; Goh BKP; Koh YX
Eur J Surg Oncol; 2024 Jan; 50(1):107277. PubMed ID: 37995605
[TBL] [Abstract] [Full Text] [Related]
7. Epidemiology of HBV-HCV Coinfection Among Iranian Patients: a Systematic Review and Meta-Analysis.
Anvari HZ; Binabaj MM; Asadi A; Abdi M; Shakiba A; Heidary M; Sholeh M
Clin Lab; 2023 Nov; 69(11):. PubMed ID: 37948496
[TBL] [Abstract] [Full Text] [Related]
8. Atezolizumab plus bevacizumab versus active surveillance in patients with resected or ablated high-risk hepatocellular carcinoma (IMbrave050): a randomised, open-label, multicentre, phase 3 trial.
Qin S; Chen M; Cheng AL; Kaseb AO; Kudo M; Lee HC; Yopp AC; Zhou J; Wang L; Wen X; Heo J; Tak WY; Nakamura S; Numata K; Uguen T; Hsiehchen D; Cha E; Hack SP; Lian Q; Ma N; Spahn JH; Wang Y; Wu C; Chow PKH;
Lancet; 2023 Nov; 402(10415):1835-1847. PubMed ID: 37871608
[TBL] [Abstract] [Full Text] [Related]
9. Nomogram to predict liver surgery-specific complications for hepatocellular carcinoma: A multicenter study.
Qi W; Dai J; Qiu Z; Wu Y; Wen T; Xie F; Gao F; Zhang Y; Li C
Eur J Surg Oncol; 2023 Dec; 49(12):107119. PubMed ID: 37871467
[TBL] [Abstract] [Full Text] [Related]
10. Combined FOLFOX4 with all-trans retinoic acid versus FOLFOX4 with placebo in treatment of advanced hepatocellular carcinoma with extrahepatic metastasis: a randomized, double-blind comparative study.
Sun J; Mao F; Liu C; Zhang F; Jiang D; Guo W; Huo L; Zhou L; Lau WY; Shi J; Cheng S
Signal Transduct Target Ther; 2023 Sep; 8(1):368. PubMed ID: 37752117
[TBL] [Abstract] [Full Text] [Related]
11. Assessing the impact of direct-acting antivirals on hepatitis C complications: a systematic review and meta-analysis.
Yew KC; Tan QR; Lim PC; Low WY; Lee CY
Naunyn Schmiedebergs Arch Pharmacol; 2024 Mar; 397(3):1421-1431. PubMed ID: 37728622
[TBL] [Abstract] [Full Text] [Related]
12. Comparing Survival After Resection, Ablation, and Radiation in Small Intrahepatic Cholangiocarcinoma.
Masoud SJ; Rhodin KE; Kanu E; Bao J; Eckhoff AM; Bartholomew AJ; Howell TC; Aykut B; Kosovec JE; Palta M; Befera NT; Kim CY; Herbert G; Shah KN; Nussbaum DP; Blazer DG; Zani S; Allen PJ; Lidsky ME
Ann Surg Oncol; 2023 Oct; 30(11):6639-6646. PubMed ID: 37436606
[TBL] [Abstract] [Full Text] [Related]
13. Loco-regional therapies competing with radiofrequency ablation in potential indications for hepatocellular carcinoma: a network meta-analysis.
Kim HI; An J; Han S; Shim JH
Clin Mol Hepatol; 2023 Oct; 29(4):1013-1028. PubMed ID: 37403319
[TBL] [Abstract] [Full Text] [Related]
14. Associations of Race and Ethnicity with Hepatocellular Carcinoma, Decompensation, and Mortality in US Veterans with Cirrhosis.
VoPham T; Cravero A; Feld LD; Green P; Feng Z; Berry K; Kim NJ; Vutien P; Mendoza JA; Ioannou GN
Cancer Epidemiol Biomarkers Prev; 2023 Aug; 32(8):1069-1078. PubMed ID: 37255388
[TBL] [Abstract] [Full Text] [Related]
15. Tertiary lymphoid structures predict the prognosis and immunotherapy response of cholangiocarcinoma.
Shang T; Jiang T; Lu T; Wang H; Cui X; Pan Y; Xu M; Pei M; Ding Z; Feng X; Lin Y; Li X; Tan Y; Feng F; Dong H; Wang H; Dong L
Front Immunol; 2023; 14():1166497. PubMed ID: 37234171
[TBL] [Abstract] [Full Text] [Related]
16. Treated chronic hepatitis B is a good prognostic factor of diffuse large B-cell lymphoma.
Park J; Chung SW; Lee YB; Shin H; Hur MH; Cho H; Park MK; Youk J; Lee JY; Lee JO; Yu SJ; Kim YJ; Yoon JH; Kim TM; Lee JH
Clin Mol Hepatol; 2023 Jul; 29(3):794-809. PubMed ID: 37196991
[TBL] [Abstract] [Full Text] [Related]
17. Prognostic values of tissue-resident CD8
Chen L; Huang H; Huang Z; Chen J; Liu Y; Wu Y; Li A; Ge J; Fang Z; Xu B; Zheng X; Wu C
World J Surg Oncol; 2023 Apr; 21(1):124. PubMed ID: 37024870
[TBL] [Abstract] [Full Text] [Related]
18. Efficacy and Dose-Response Relationship of Stereotactic Body Radiotherapy for Abdominal Lymph Node Metastases from Hepatocellular Carcinoma.
Wang Y; Li Q; Zhang L; Liu S; Zhu J; Yang Y; Liu M; Zhang Y; Xi M
Oncologist; 2023 Jun; 28(6):e369-e378. PubMed ID: 37011232
[TBL] [Abstract] [Full Text] [Related]
19. C1orf109 promotes malignant phenotype of liver cancer via wnt signaling pathway in a CK2-dependent manner.
Sun J; Zhang X; Sun Y
J Mol Histol; 2023 Apr; 54(2):135-145. PubMed ID: 36988773
[TBL] [Abstract] [Full Text] [Related]
20. The predictive value of PD-L1 expression in patients with advanced hepatocellular carcinoma treated with PD-1/PD-L1 inhibitors: A systematic review and meta-analysis.
Yang Y; Chen D; Zhao B; Ren L; Huang R; Feng B; Chen H
Cancer Med; 2023 Apr; 12(8):9282-9292. PubMed ID: 36965092
[TBL] [Abstract] [Full Text] [Related]
[Next]
